PMID- 23658190 OWN - NLM STAT- MEDLINE DCOM- 20130806 LR - 20230425 IS - 1529-2401 (Electronic) IS - 0270-6474 (Print) IS - 0270-6474 (Linking) VI - 33 IP - 19 DP - 2013 May 8 TI - Small-molecule screen in adult Drosophila identifies VMAT as a regulator of sleep. PG - 8534-40 LID - 10.1523/JNEUROSCI.0253-13.2013 [doi] AB - Sleep is an important physiological state, but its function and regulation remain elusive. In Drosophila melanogaster, a useful model organism for studying sleep, forward genetic screens have identified important sleep-modulating genes and pathways; however, the results of such screens may be limited by developmental abnormalities or lethality associated with mutation of certain genes. To circumvent these limitations, we used a small-molecule screen to identify sleep-modulating genes and pathways. We administered 1280 pharmacologically active small molecules to adult flies and monitored their sleep. We found that administration of reserpine, a small-molecule inhibitor of the vesicular monoamine transporter (VMAT) that repackages monoamines into presynaptic vesicles, resulted in an increase in sleep. Supporting the idea that VMAT is the sleep-relevant target of reserpine, we found that VMAT-null mutants have an increased sleep phenotype, as well as an increased arousal threshold and resistance to the effects of reserpine. However, although the VMAT mutants are consistently resistant to reserpine, other aspects of their sleep phenotype are dependent on genetic background. These findings indicate that small-molecule screens can be used effectively to identify sleep-modulating genes whose phenotypes may be suppressed in traditional genetic screens. Mutations affecting single monoamine pathways did not affect reserpine sensitivity, suggesting that effects of VMAT/reserpine on sleep are mediated by multiple monoamines. Overall, we identify VMAT as an important regulator of sleep in Drosophila and demonstrate that small-molecule screens provide an effective approach to identify genes and pathways that impact adult Drosophila behavior. FAU - Nall, Aleksandra H AU - Nall AH AD - Cell and Molecular Biology Program and Department of Neuroscience, Howard Hughes Medical Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA. FAU - Sehgal, Amita AU - Sehgal A LA - eng GR - T32 HL007953/HL/NHLBI NIH HHS/United States GR - 5 T32 HL 7953-12/HL/NHLBI NIH HHS/United States GR - 5-PO1-AG-017628/AG/NIA NIH HHS/United States GR - P01 AG017628/AG/NIA NIH HHS/United States GR - HHMI_/Howard Hughes Medical Institute/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - J Neurosci JT - The Journal of neuroscience : the official journal of the Society for Neuroscience JID - 8102140 RN - 0 (Antipsychotic Agents) RN - 0 (Biogenic Monoamines) RN - 0 (Drosophila Proteins) RN - 0 (RNA, Messenger) RN - 0 (Vesicular Monoamine Transport Proteins) SB - IM MH - Analysis of Variance MH - Animals MH - Animals, Genetically Modified MH - Antipsychotic Agents/pharmacology MH - Arousal/drug effects/genetics MH - Behavior, Animal/drug effects/physiology MH - Biogenic Monoamines/metabolism MH - Drosophila MH - Drosophila Proteins/genetics MH - Female MH - Genetic Testing MH - Mutation MH - Phenotype MH - RNA, Messenger/metabolism MH - Reaction Time/drug effects/genetics MH - Sleep/drug effects/*genetics MH - Sleep Deprivation MH - Vesicular Monoamine Transport Proteins/genetics/*metabolism PMC - PMC3677510 MID - NIHMS477099 OID - NLM: HHMIMS477099 EDAT- 2013/05/10 06:00 MHDA- 2013/08/07 06:00 PMCR- 2013/11/08 CRDT- 2013/05/10 06:00 PHST- 2013/05/10 06:00 [entrez] PHST- 2013/05/10 06:00 [pubmed] PHST- 2013/08/07 06:00 [medline] PHST- 2013/11/08 00:00 [pmc-release] AID - 33/19/8534 [pii] AID - 0253-13 [pii] AID - 10.1523/JNEUROSCI.0253-13.2013 [doi] PST - ppublish SO - J Neurosci. 2013 May 8;33(19):8534-40. doi: 10.1523/JNEUROSCI.0253-13.2013.